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AIM The aim of this study was to investigate the association between heavy maternal alcohol
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METHOD The records of all mothers with an International Classification of Diseases, revision 9 or

ABBREVIATIONS

FAS
ICD

Fetal alcohol syndrome
International Classification of
Diseases

consumption and pre- peri- and postneonatally acquired cerebral palsy (CP).
10 (ICD-9 ⁄ -10) alcohol-related diagnostic code, indicating heavy alcohol consumption, recorded
on population-based health, mental health, and drug and alcohol data sets from 1983 to 2007, and
their children were identified through the Western Australian Data-linkage System. This ‘exposed’
cohort was frequency matched with mothers without an alcohol-related diagnosis and their
offspring (comparison group). Cases of CP were identified through linkage with the Western
Australia CP Register. Analyses were undertaken using multivariate logistic regression.
RESULTS There were 23 573 live births in the exposed group (58.6% non-Aboriginal; 41.4%
Aboriginal) and 292 cases of CP. The odds of pre ⁄ perinatally acquired CP were elevated for
children of non-Aboriginal mothers with an alcohol-related diagnosis recorded during pregnancy
(adjusted odds ratio 3.32; 95% confidence interval [CI] 1.30–8.48) and for Aboriginal children when
an alcohol-related diagnosis was recorded up to 12 months before the mother’s pregnancy
(adjusted odds ratio 2.49; 95% CI 0.99–6.25). Increased odds of postneonatally acquired CP
following any alcohol-related diagnosis were found for non-Aboriginal children (adjusted odds
ratio 7.92; 95% CI 2.23–28.14).
INTERPRETATION These results suggest that heavy maternal alcohol consumption is a direct
cause of pre ⁄ perinatally acquired CP, and an indirect cause of postneonatally acquired CP, in
non-Aboriginal children. The lack of an association for Aboriginal children requires further
investigation but may be due to under ascertainment of alcohol use disorders during pregnancy
and other aetiological pathways.

Maternal alcohol use disorders, indicating alcohol abuse,
harmful use, or dependence,1 are biological, psychological,
and environmental risk factors for the offspring.2 Children are
at risk of being exposed to a number of interacting factors
stemming from the environment and the family which
increase the risk of developing adverse health and cognitive
and psychosocial problems.
Heavy maternal alcohol use occurring during pregnancy
increases the risk of a range of fetal effects, many of which
are included under the umbrella term fetal alcohol spectrum
disorders.3 Cerebral palsy (CP) is among the possible diagnostic features of structural or neurological brain damage
related to prenatal alcohol exposure.4,5 However, the evidence to support this association is not strong.6 A handful of
studies have reported a prevalence of CP in children with
fetal alcohol syndrome of between 2% and 10%, but these
are based on small numbers7–10 and many studies lack scientific rigour.6

The prevalence of CP has remained relatively stable over
the past decade11 and, although the majority (82–91%) of
cases of CP are thought to be due to prenatal or perinatal factors, few prenatal causes have been identified.12 Therefore,
identifying modifiable risk factors is a priority; however, CP is
a rare condition11,12 and health professionals do not routinely
ask mothers about their alcohol use during pregnancy.13
Therefore, research into the relationship between prenatal
alcohol exposure and CP is difficult to conduct.
The aim of this study was to investigate the association
between heavy levels of maternal alcohol use before, during,
and after pregnancy and CP in the children of these mothers,
using a population-based cohort.
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METHOD
Participants
The population at risk were all women who gave birth in
Western Australia between 1983 and 2007. All mothers with

an alcohol-related diagnosis, used as a proxy for heavy levels
of alcohol consumption, were identified along with their
children through linked, population-based data from the
Western Australian Data-linkage System.14 The exposed
cohort comprised all mothers with an alcohol-related diagnosis (International Classification of Diseases, revision 9 or 10
[ICD-9 and ⁄ or ICD-10]) recorded on one or more of the
Western Australian Hospital Morbidity data sets (which
include information on hospital in-patient admissions), the
Midwives Notification System, or the Mental Health Outpatients data set, or who had been treated for an alcohol problem at the Perth-based government Drug and Alcohol Office
treatment services, and all offspring whose birth was recorded
on the Midwives Notification System (1983–2007). The ICD9 and ⁄ or ICD-10 codes included alcohol-related mental and
behavioural disorders, an alcohol-related disease with a 100%
attributable fraction, and other alcohol codes. (Appendix 1,
supporting information published online).
The exposed cohort was frequency matched on maternal
age within maternal race (Aboriginal: 2–3 unexposed: 1
exposed; non-Aboriginal: 3–4 unexposed: 1 exposed) and year
of birth of the child to mothers in the Midwives Notification
System without an alcohol-related diagnosis (ICD-9 and ⁄ or
ICD-10) recorded on the Hospital Morbidity data sets or the
Mental Health Outpatients or Drug and Alcohol Office data
sets. The selection of the comparison group also excluded
women with an ICD-8 alcohol diagnostic code occurring in
the Hospital Morbidity data sets from 1970 to 1983 and the
Mental Health Outpatients data set between 1966 and 1983.
The records of the selected women and all their children
whose births are recorded on the Midwives Notification
System are referred to as the comparison group.
Records from the exposed and comparison cohorts were
linked by the Western Australia Data-linkage Branch using
probabilistic matching,14 and de-identified data files were provided to the researchers. The data from both cohorts were
linked with the Western Australian CP Register, which
includes all cases of CP in Western Australia occurring from
1956 onwards.11,12 Cases are actively ascertained from multiple sources, and all information is updated at 5 years of age
and classified as either pre-, peri-, or postneonatally
acquired.11
Children in both cohorts with a diagnosis of fetal alcohol
syndrome (FAS) were identified through linkage with the
Western Australian Birth Defects Register, which collects
information for the Western Australia population on birth
defects diagnosed in stillbirths, terminations of pregnancy, and
live births up to 6 years of age, using multiple sources of ascertainment.15 The Birth Defects and CP Registers are now combined and known as the Western Australian Register of
Developmental Anomalies.

Statistical analysis and covariates
Maternal alcohol-related diagnosis was coded into (1) a binary
variable (yes ⁄ no), and (2) the timing of recording of the alcoholrelated diagnosis in relation to pregnancy using a hierarchical
coding with the order as follows: (a) any record during preg-

What this paper adds
• Children of non-Aboriginal and Aboriginal mothers with an alcohol-related
diagnosis are at increased risk of pre ⁄ perinatally acquired CP.
• Increased odds of postneonatally acquired CP were observed only in children
of non-Aboriginal mothers.
• These results suggest that a maternal alcohol use disorder is both a direct
and indirect risk factor for CP in the offspring.

nancy, which may also include an alcohol-related diagnosis
before and ⁄ or after pregnancy; for women without a diagnosis
during pregnancy, the groups were (b) up to 1 year before
pregnancy and may include exposure of more than 1 year
before pregnancy or any exposure after pregnancy, (c) up to 1
year after pregnancy and may include exposure for more than
1 year before or after pregnancy, (d) more than 1 year before
pregnancy and may include exposure more than 1 year after
pregnancy, and (e) more than 1 year after pregnancy (Table I).
The pregnancy period was estimated by subtracting gestational age16 at birth from date of birth to give the date of conception.
The proportion of CP cases for the exposed and comparison groups was calculated for all CP and for pre-, peri-, and
postneonatally acquired CP for Aboriginal and non-Aboriginal children separately and presented per 1000 live births,
along with the odds ratio and with 95% CIs (Table II). The
proportion of CP in children with FAS is presented per 1000
children with FAS.
Multivariate logistic regression analysis was used to examine
the odds of CP in live births of mothers with an alcoholrelated diagnosis compared with children of mothers in the
comparison group. All analyses were stratified by Aboriginal
status and adjusted for year of birth and maternal age used in
the frequency matching. To examine whether the relationship
between exposure and CP was causal or due to postnatal environmental factors, the analyses were repeated separately for
pre-, peri-, and postneonatally acquired CP. Postneonatal
analyses included only children alive at 29 days of age. Preterm
birth and intrauterine growth restriction are known to increase
the risk of CP17 and may be associated with prenatal alcohol
exposure,18 so the binary analyses examining pre ⁄ perinatally
acquired CP were further restricted to examine the association
for (1) term births, defined as births at 37+ weeks’ gestation
(non-Aboriginal, n=4573 [8.5%] excluded; Aboriginal, n=5193
[17%] excluded) and (2) appropriate fetal growth (nonAboriginal, n=5677 [10.5%] excluded; Aboriginal, n=5980
[19.7%] excluded). The proportion of optimal birthweight
was used as a measure of fetal growth, where optimal birthweight was determined after taking into account infant sex,
gestational age, maternal height, and parity.19 A proportion of
the optimal birthweight score on the 10th centile or higher
was used to define appropriate fetal growth.
Maternal characteristics, behaviours, and pregnancy complications that were considered potential confounders were
entered individually into the univariate model and those that
altered the univariate odds ratios (ORs) by 20% or greater
were included as possible confounders in the multivariate
logistic analyses. Variables assessed as possible confounders
included marital status, parity, maternal illicit drug use (any
Maternal Alcohol Consumption and CP Colleen M O'Leary et al. 225

Table I: Coding of timing of maternal alcohol-related diagnosis in relation to pregnancy
Timing of maternal alcohol-related diagnosis in relation to pregnancy

During pregnancy
£1y before pregnancy
£1y after pregnancy
>1y before pregnancy
>1y after pregnancy

During

£1y before

£1y after

>1y before

>1y after

Yes
No
No
No
No

Possible
Yes
No
No
No

Possible
Possible
Yes
No
No

Possible
Possible
Possible
Yes
No

Possible
Possible
Possible
Possible
Yes

Table II: Maternal demographic characteristics at each live birth 1980–2007, n (%)
Non-Aboriginal (n=53 955)
Characteristic
Maternal age (y)
<20
20–24
25–29
30–34
35–39
40+
Marital status
Married
Never married
Singlea
Illicit drug useb
Socio-economic status
Most advantaged >10%
10 to £25%
25 to £50%
50 to £75%
75 to £90%
10%
Unknown
Pregnancy complications
Threatened abortion <20wks
Threatened preterm labour
Antepartum haemorrhage ⁄ placenta abruption
Health service region
Perth metro
Rural ⁄ remote
Other
Maternal smokingc (1998–2007)

Exposed (n=13 807)

Aboriginal (n=30 409)

Comparison (n=40 148)

Exposed (n=9766)

Comparison (n=20 643)

1676 (12.1)
4089 (29.6)
4062 (29.4)
2689 (19.5)
1086 (7.9)
205 (1.5)

4755 (11.8)
11 764 (29.3)
11 944 (29.7)
7869 (19.6)
3211 (8.0)
605 (1.5)

2587 (26.5)
3232 (33.1)
2245 (23.0)
1202 (12.3)
448 (4.6)
52 (0.5)

5421 (26.3)
6909 (33.4)
4743 (23.0)
2520 (12.2)
933 (4.5)
117 (0.6)

10 168 (73.9)
3065 (22.3)
520 (3.8)
2891 (20.9)

34 700 (86.5)
5056 (12.6)
356 (0.9)
551 (1.4)

5680 (58.6)
3807 (39.2)
213 (2.2)
916 (9.4)

13 455 (65.5)
6726 (32.8)
355 (1.7)
436 (2.1)

557 (4.0)
1215 (8.8)
2507 (18.2)
3372 (24.4)
2595 (18.8)
1983 (14.4)
1578 (11.4)

2711 (6.8)
5071 (12.6)
8623 (21.5)
9458 (23.6)
5993 (14.9)
3478 (8.7)
4814 (12.0)

24 (0.2)
83 (0.8)
471 (4.8)
1274 (13.0)
1831 (18.7)
2903 (29.7)
3180 (32.6)

108 (0.5)
358 (1.7)
1404 (6.8)
3410 (16.5)
4448 (21.6)
6110 (29.6)
4784 (23.2)

756 (5.5)
288 (2.1)
145 (1.1)

2008 (5.0)
431 (1.1)
226 (0.6)

154 (1.6)
261 (2.7)
69 (0.7)

386 (1.9)
401 (1.9)
111 (0.5)

9891 (71.6)
3858 (27.9)
58 (0.4)

28 986 (72.2)
10 893 (73.8)
269 (0.7)

2874 (29.4)
6873 (70.4)
19 (0.2)

6631 (32.1)
13 956 (67.6)
56 (0.3)

n=5531
2757 (49.8)

n=16 255
3266 (20.1)

n=3556
2410 (67.5)

n=8329
3764 (45.2)

a

Includes widowed or divorced. bAny ICD-9 and ⁄ or ICD-10 code for illicit drugs present on either the Hospital Morbidity or Mental Health
Outpatients data sets, or illicit drug use recorded on the Drug and Alcohol Office data set. cCollected on the Midwives Notification System since
1998.

ICD-9 ⁄ ICD-10 code for illicit drugs present on either the
Hospital Morbidity data sets or the Mental Health Outpatients data sets, or illicit drug use recorded on the Drug and
Alcohol Office data set), threatened abortion at less than 20
weeks, threatened preterm labour, antepartum haemorrhage–
placental abruption, socio-economic status at time of birth
based on Australian census data collected at the census district
level (approximately 200 households)20 stratified into quintiles,
and maternal smoking during pregnancy. The only potential
confounding variables to alter the OR by 20% or more, and
hence included in the multivariate analyses, were illicit drug
use for all CP and pre ⁄ perinatally acquired CP and socioeconomic status for postneonatally acquired CP in non226 Developmental Medicine & Child Neurology 2012, 54: 224–230

Aboriginal children. No variables altered the odds by more
than 20% in the analyses in Aboriginal children. Logistic
regression analyses were conducted using SPSS version 17.0
(SPSS Inc., Chicago, IL, USA). Results are presented as ORs
with 95% CIs.
The population-attributable fraction and 95% CI was calculated for significant findings for exposure during pregnancy21 using whole Western Australian population numbers
for the comparison numerators and denominators.
Ethics approval for the conduct of this study was granted by
the Princess Margaret Hospital Research Ethics Committee,
the Western Australia Department of Health Confidentiality
of Health Information Committee (now called the Health

Research Ethics Committee), the Western Australia Aboriginal Health Information Ethics Committee, and the Curtin
Human Research Ethics Committee. A requirement of
Western Australia ethics committees is that researchers using
linked data are not permitted to report numbers where the
number of cases within a stratum is less than 5 to prevent the
likelihood of identification of individuals.

RESULTS
There were 84 364 children in the study; 53 955 (64.0%) were
non-Aboriginal, of whom 13 807 (25.6%) were exposed, and
30 409 (36.0%) were Aboriginal, of whom 9766 (32.1%) were
exposed (Table II). Mothers with an alcohol-related diagnosis
were less likely to be married and more likely to use illicit
drugs and smoke cigarettes than those in the comparison
group, and the percentage of exposed mothers using
illicit drugs was higher in non-Aboriginal than in Aboriginal
mothers, while maternal smoking was more prevalent in
non-Aboriginal mothers. Non-Aboriginal mothers were older
than Aboriginal mothers, had more pregnancy complications,
and were more affluent, with 31% of exposed and 41% of
comparison mothers in the top 50% of socio-economic status
compared with 6% and 9% (respectively) of Aboriginal mothers. Over 70% of non-Aboriginal mothers and 30% of Aboriginal mothers lived in Perth at the time of birth (Table II).
There were 292 children with CP, of whom 59 non-Aboriginal children were exposed and 96 were comparison children,
and 39 Aboriginal children were exposed and 98 were comparison children. The proportion of all CP in non-Aboriginal
offspring was 4.3 per 1000 for exposed and 2.4 per 1000 for
comparison offspring, giving a ratio of 1.8 (95% CI 1.58–
2.08), with a similar distribution for pre ⁄ perinatally acquired
CP. In Aboriginal children, the proportion of all CP was 3.99
per 1000 in the exposed and 4.70 in the comparison groups,
with a ratio of 0.84 (95% CI 0.70–0.98), with a similar proportion for pre ⁄ perinatally acquired CP. The ratio for postneonatally acquired CP in non-Aboriginal children was 5.8 (95% CI
3.12–8.48) compared with 0.79 (95% CI 0.56–1.02) for
Aboriginal children (Table SI, supporting information published online only). There were 124 live born children diagnosed with FAS on the Western Australian Register of
Developmental Anomalies and nine had pre ⁄ perinatally
acquired CP (72.6 ⁄ 1000 children with FAS; results not
shown).
The timing of the alcohol-related diagnosis in relation to
pregnancy for cases of CP is shown in Table SII (supporting
information published online only). The majority of children
had a mother with a diagnosis recorded more than 1 year after
pregnancy (59.4% of non-Aboriginal and 63.2% of Aboriginal
mothers), followed by a diagnosis more than 1 year before
pregnancy (27.1% of non-Aboriginal and 16.7% of Aboriginal
mothers). The percentage of Aboriginal mothers with a diagnosis recorded during pregnancy (8.5%) was over twice that of
non-Aboriginal mothers (3.8%). There were six cases of CP
(3.8%) in which the non-Aboriginal mother had an alcoholrelated diagnosis recorded during pregnancy and for Aboriginal mothers five cases had a diagnosis recorded within the 12

months before pregnancy and fewer than five cases had a diagnosis recorded during pregnancy.
The severity of CP varied by ethnicity, with a higher percentage of non-Aboriginal children (52.6%) than Aboriginal
children (30.7%) having either minimal or mild CP (classification based on clinical notes equates approximately to Gross
Motor Function Classification System ⁄ Manual Ability Classification System levels I or II),22,23 and there was little variation
in the distribution of severity by exposure status. Causes were
documented for all 63 children with postneonatal CP. Head
injury was the cause in half (50.0%) of the non-Aboriginal and
22.7% of the Aboriginal children and infection for 22.2% of
non-Aboriginal and over half (63.6%) of Aboriginal children.
Causes of head injury were passenger or pedestrian motor
vehicle accident (n=8; 12.9%), non-accidental head injury
(n=6; 9.7%), and fall or other non-specified head injury (n=5;
8.0%; results not shown).
The results of the multivariate logistic regression examining
CP (yes ⁄ no) as the outcome variable and maternal alcohol
diagnosis (yes ⁄ no) as the exposure variable showed a small
increase in all CP for non-Aboriginal children (adjusted OR
1.40; 95% CI 0.97–2.02), with similar odds following stratification for term births and optimal birthweight (Table III).
Adjusting for maternal smoking (1998–2007) did not alter this
association by more than 20% (results not shown). An eightfold increased odds of postneonatally acquired CP (adjusted
OR 7.92; 95% CI 2.23–28.14) was observed for non-Aboriginal children. In Aboriginal children, there was no association
between the binary alcohol variable and CP in any of the
models (Table III). The population-attributable fraction for
non-Aboriginal CP when a maternal alcohol-related diagnosis
was recorded during pregnancy was 0.28 (95% CI )0.00002
to 0.70; results not shown).
Multivariate logistic regression examining the timing of
maternal alcohol diagnosis in relation to pregnancy showed a
threefold increased odds of non-Aboriginal CP when a diagnosis was recorded during pregnancy (adjusted OR 3.72 [95%
CI 1.57–8.81]), which remained in the analyses examining
pre ⁄ perinatally acquired CP (adjusted OR 3.32; 95% CI 1.30–
8.48; Table IV). The increased odds for all CP when an
alcohol diagnosis was recorded more than 1 year before pregnancy (adjusted OR 1.83; 95% CI 1.07–3.13) reduced when
pre ⁄ perinatally acquired CP was examined (adjusted OR 1.51;
95% CI 0.83–2.73). Small numbers of CP in Aboriginal children in some alcohol-exposure groups limited investigation of
the timing of maternal alcohol-related diagnoses. However,
twofold increased odds of pre ⁄ perinatally acquired CP were
observed when an alcohol-related diagnosis was recorded
within 12 months of pregnancy (adjusted OR 2.49; 95% CI
0.99–6.25).

DISCUSSION
This study demonstrates that a maternal alcohol-related diagnosis, indicating heavy maternal alcohol drinking, increases
the risk of both pre ⁄ perinatally and postneonatally acquired
CP in non-Aboriginal children. The threefold increased odds
of pre ⁄ perinatally acquired CP (adjusted OR 3.32; 95% CI
Maternal Alcohol Consumption and CP Colleen M O'Leary et al. 227

Table III: Adjusted odds ratio (and 95% confidence interval) of all cerebral palsy (CP) and pre ⁄ perinatally and postneonatally acquired cerebral palsy for children of mothers with an alcohol-related diagnosis, by Aboriginal status
Pre ⁄ perinatala
All CP

Term birthsb

All

Non-Aboriginal (n=53 955)
Alcohol-related diagnosis
1.00f
No 1.00e
1.40f
Yes 1.79e
(1.29–2.48) (0.97–2.02)

1.00e
1.51e
(1.06–2.15)

Aboriginal (n=30 409)
No 1.00e
Yes 0.83e
(0.57–1.20)

1.00e
0.87e
(0.56–1.37)

–h
–h

1.00f
1.21f
(0.81–1.80)
–h
–h

1.00e
1.63e
(1.04–2.56)
1.00e
0.81e
(0.43–1.53)

1.00f
1.37f
(0.83–2.27)
–h
–h

Optimal birthweightc

Postneonatald

1.00e
1.62e
(1.10–2.39)

1.00e
4.34e
(1.45–12.98)

1.00e
0.80e
(0.44–1.43)

1.00f
1.31f
(0.85–2.02)
–h
–h

1.00e
0.68e
(0.28–1.68)

1.00g
7.92g
(2.23–28.14)
–h
–h

Live births. b37+ weeks’ gestation. cIncludes the top 90% of optimal birthweight. dOnly children alive at 29 days are included in the
denominator. eAdjusted for variables used in frequency matching: maternal age, and year of birth. fAdjusted for variables used in frequency
matching and illicit drug use. gAdjusted for variables used in frequency matching and socio-economic status. hNo potential confounder altered
the odds by ‡20%.

a

Table IV: Adjusted odds ratio (and 95% confidence intervals) of cerebral palsy for non-Aboriginal and Aboriginal children by timing of maternal alcoholrelated diagnosis in relation to pregnancy
All CPa

Timing of alcohol-related diagnosis
Non-Aboriginal (n=53 955)
No alcohol-related diagnosis
During pregnancy
£1y before pregnancy
£1y after pregnancy
>1y before pregnancy
>1y after pregnancy

1.00b
5.01b (2.16–11.60)
<5
<5
2.16b (1.28–3.65)
1.49b (0.98–2.26)

Aboriginal (n=30 409)
No alcohol-related diagnosis
During pregnancy
£1y before pregnancy
£1y after pregnancy
>1y before pregnancy
>1y after pregnancy

1.00b
0.59b (0.14–2.41)
1.76b (0.71–4.39)
<5
<5
0.84b (0.54–1.30)

Pre ⁄ perinatally acquired CPa
1.00c
3.72c (1.57–8.81)
<5
<5
1.83c (1.07–3.13)
1.11c (0.70–1.76)
–d
–d
–d
–d
–d
–d

1.00b
4.33b (1.74–10.82)
<5
<5
1.75b (0.98–3.13)
1.27b (0.81–2.02)
1.00b
0.81b (0.20–3.33)
2.49b (0.99–6.25)
<5
<5
0.85b (0.49–1.46)

1.00c
3.32c (1.30–8.48)
<5
<5
1.51c (0.83–2.73)
0.98c (0.59–1.62)
–d
–d
–d
–d
–d
–d

Live births. bAdjusted for variables used in frequency matching: maternal age, and year of birth. cAdjusted variables used in frequency matching
and illicit drug use. dNo potential confounder altered the odds by ‡20.

a

1.30–8.48) for non-Aboriginal children was demonstrated only
when the maternal alcohol diagnosis was recorded during
pregnancy. However, the population-attributable fraction,
assuming causality, is low and imprecise, indicating that prevention of heavy maternal alcohol consumption in this group
of mothers would prevent less than 0.5% of CP cases. The
eightfold increased odds of postneonatally acquired CP in
non-Aboriginal children for any alcohol-related diagnosis
(adjusted OR 7.92; 95% CI 2.23–28.14) supports the theory
that heavy maternal alcohol consumption is both a direct and
an indirect risk factor for the offspring.2 The small numbers of
postneonatally acquired CP prevented investigation of
whether a postnatal alcohol diagnosis was associated with
higher odds than diagnoses recorded either during pregnancy
or prenatally. However, it is recognized that heavy maternal
alcohol use continuing after pregnancy exposes the offspring
to interacting risk factors stemming from the environment and
the family, which increases the risk of health, mental health,
228 Developmental Medicine & Child Neurology 2012, 54: 224–230

behaviour, development and educational problems, and child
abuse and neglect.2
The lack of an association between an alcohol-related diagnosis recorded during pregnancy and pre ⁄ perinatally acquired
CP in Aboriginal children was unexpected and may reflect the
high proportion of Aboriginal children with CP in the comparison group. However, the increased odds when the diagnosis was recorded within 12 months before pregnancy (adjusted
OR 2.49; 95% CI 0.99–6.25) suggests that these mothers continued to drink heavily during pregnancy and there may be
under ascertainment of maternal alcohol problems during
pregnancy. This may have masked an association. The lack of
alcohol service data for Aboriginal-specific and rural services,
the high percentage of Aboriginal mothers in this study living
in rural ⁄ remote regions, and the evidence that high-risk drinking and alcohol-related harm are more common in
rural ⁄ remote regions than in metropolitan regions in Australia24 support this assumption.

We did not find an association between maternal alcohol
consumption and postneonatally acquired CP in Aboriginal
children, which may be due to multiple health and environmental contributors to risk in these children. For example, the
Aboriginal population is more likely to have complex, chronic
health problems than the non-Aboriginal population,25,26 is
less likely to access antenatal services,27 and is more likely to
be of low socio-economic status. The findings that 63.6% of
postneonatally acquired CP in Western Australia was associated with infection for Aboriginal children and that 50.0% of
CP in non-Aboriginal children was attributable to head injury
were not unexpected as these have been documented previously.12 These indicate different aetiological pathways for
postneonatally acquired CP, leading us to question whether
this may also be the case for pre ⁄ perinatally acquired CP.
We need to exercise caution in our interpretation of the
data as an alcohol-related diagnosis was recorded in the
mother during pregnancy in only a small number of cases.
However, the proportion of pre ⁄ perinatally acquired CP in
children with FAS (73 ⁄ 1000) is consistent with the findings of
other studies7–10 and lends support to the validity of the findings from this study. The small number of cases of CP in our
study limited our analyses of many categories and highlights
the difficulty in examining the association between prenatal
alcohol exposure and CP even in a large population-based
study such as this one. CP is a rare outcome,11,12 and pregnant
women13 and individuals admitted to general hospital and psychiatric facilities28 are not routinely asked about their alcohol
consumption. The women in this study have serious alcoholrelated problems and require non-judgemental treatment and
support. Routinely asking women of childbearing age and
pregnant women about their alcohol use should become standard practice and be supported with appropriate brief interventions and referral to alcohol treatment and family support
services where indicated.
While we are confident that the mothers with an alcoholrelated diagnosis in this study were drinking heavily, many
women drinking at heavy levels will not have been identified.29
So it is likely that at least some of the comparison mothers will
also have alcohol-related problems unreported in the data sets
used in this study, resulting in an underestimate of the true
level of association. In spite of this, the two- to threefold
increased odds of CP found for non-Aboriginal children in
this study are on a parallel with other identified CP risk factors
such as preterm birth, low birthweight, and infections.17
Finally, it is possible that CP in Aboriginal children is underascertained and that the true number of children with CP is
higher than reported here. Changes in the privacy legislation
in Western Australia in 2001 resulted in a decrease in the
response rate from clinicians, particularly in regional areas

where a higher proportion of the population is Aboriginal.
However, the CP Register uses multiple sources of ascertainment to identify children with CP and the stability of trends
over time supports the robustness of the CP Register. Also,
there is no evidence to indicate that underascertainment of CP
would occur more frequently in the children of mothers with
an alcohol-related diagnosis than in the comparison group. In
2011, mandatory reporting of birth defects and CP was legislated in Western Australia and so validation of the prevalence
of CP on the Western Australian Register of Developmental
Anomalies will be possible in a few years.
Although CP is rare, it was estimated that around 34 000
Australians in 2007 had CP, and CP carries higher disability
burden and costs than many other forms of disability.30 The
findings of this study add strength to the evidence of an association between prenatal alcohol exposure and CP, which is one
of only a few potentially modifiable risk factors that have been
identified for both pre- and postneonatally acquired CP.

CONCLUSIONS
Harmful maternal alcohol use is a potentially modifiable risk
factor for CP. Children of non-Aboriginal mothers with an
alcohol-related diagnosis recorded during pregnancy have
increased odds of pre ⁄ perinatally acquired CP, indicative of a
direct ⁄ causal association, and postneonatally acquired CP,
indicative of an indirect ⁄ environmental risk factor. However,
the percentage of non-Aboriginal children with CP attributable to heavy prenatal alcohol use in this cohort is less than
0.5%. The 2.5-fold increased odds of pre ⁄ perinatally acquired
CP for Aboriginal children when a maternal alcohol-related
diagnosis was recorded in the 12 months before pregnancy
suggests a lack of identification of alcohol use disorders during
pregnancy.
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